Tommy Bramley

Tommy Bramley explains how real-world evidence is reshaping how specialty pharma demonstrates value — from trial design to payer negotiations and patient outcomes.

Tommy Bramley breaks down the benefits of incorporating real world evidence and data early into a product's lifecycle.

Tommy Bramley explains how real-world evidence can be leveraged to benefit patient outcomes in specialty pharma.